Injective is showing bullish reversal potential as a double-bottom pattern forms above the $4.00 support zone, with traders watching $5.50 for breakout confirmation. Growing institutional adoption and Injective’s SEC-registered transfer agent status are also strengthening its tokenization narrative and supporting the long-term outlook for INJ.
